141 related articles for article (PubMed ID: 26015178)
1. [Distinguished award for the prokinetic drug prucalopride].
Wedekind S
MMW Fortschr Med; 2015 Apr; 157(6):10-1. PubMed ID: 26015178
[No Abstract] [Full Text] [Related]
2. [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
Layer P; Dathe K; Dignass A; Faiss S; Galle P; Lerch MM; Malfertheiner P; Wehrmann T; Zeuzem S
Z Gastroenterol; 2011 Aug; 49(8):969-70. PubMed ID: 21796580
[No Abstract] [Full Text] [Related]
3. Motility: prucalopride for chronic constipation.
Bassotti G; Villanacci V
Nat Rev Gastroenterol Hepatol; 2009 Jun; 6(6):324-5. PubMed ID: 19494821
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of prucalopride in adults and children with chronic constipation.
Diederen K; Mugie SM; Benninga MA
Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
[TBL] [Abstract][Full Text] [Related]
5. Prucalopride succinate for the treatment of constipation: an update.
Bassotti G; Gambaccini D; Bellini M
Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
[TBL] [Abstract][Full Text] [Related]
6. Use of prucalopride in adults with chronic idiopathic constipation.
Vijayvargiya P; Camilleri M
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
[No Abstract] [Full Text] [Related]
7. Oral prucalopride in children with functional constipation.
Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
[TBL] [Abstract][Full Text] [Related]
8. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
Bassotti G; Usai Satta P; Bellini M
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
[TBL] [Abstract][Full Text] [Related]
9. Luminal 5-HT
Gwynne RM; Bornstein JC
Neurogastroenterol Motil; 2019 Oct; 31(10):e13708. PubMed ID: 31524331
[TBL] [Abstract][Full Text] [Related]
10. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
Tack J; Corsetti M
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
[TBL] [Abstract][Full Text] [Related]
11. Prucalopride: For functional constipation only?
Bellini M; Gambaccini D; Bassotti G
Tech Coloproctol; 2016 Jul; 20(7):433-6. PubMed ID: 27174045
[TBL] [Abstract][Full Text] [Related]
12. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
[TBL] [Abstract][Full Text] [Related]
13. Prucalopride: a new drug for the treatment of chronic constipation.
Tack J
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
[TBL] [Abstract][Full Text] [Related]
14. [Some practical questions on chronic stipsis treatment with prucalopride].
Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
[TBL] [Abstract][Full Text] [Related]
15. Prokinetic actions of luminally acting 5-HT
Konen JR; Haag MM; Guseva D; Hurd M; Linton AA; Lavoie B; Kerrigan CB; Joyce E; Bischoff SC; Swann S; Griffin L; Matsukawa J; Falk MD; Gibson TS; Hennig GW; Wykosky J; Mawe GM
Neurogastroenterol Motil; 2021 Apr; 33(4):e14026. PubMed ID: 33185015
[TBL] [Abstract][Full Text] [Related]
16. Prucalopride in a case of severe opioid induced constipation.
Dagtekin O
Minerva Anestesiol; 2012 Apr; 78(4):513-4. PubMed ID: 22310195
[No Abstract] [Full Text] [Related]
17. Role of prucalopride in treatment of chronic constipation and recurrent functional obstruction in a patient with steinert myotonic dystrophy.
Giglio MC; Luglio G; Tarquini R; Cerbone D; Bucci P; Bucci L
J Clin Gastroenterol; 2015 Jan; 49(1):85-6. PubMed ID: 24804990
[No Abstract] [Full Text] [Related]
18. Prucalopride. In chronic constipation: poorly documented risks.
Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
[TBL] [Abstract][Full Text] [Related]
19. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
20. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
